Webinar · Palm Beach, Florida

GMP for combination products, a close look at 21 CFR Part 4

Education, Training

Next editionNot confirmedLast edition we have: 3 Mar 2015
Last venueOnlineWebinar
RunningSince 2015Frequency unknown · 1 edition on record
Last checked12 Nov 2026Its old website no longer answers
We haven't confirmed the next dates yet. The last edition in our records was 3 Mar 2015 at Webinar Venue. Its old website no longer answers, so the show may have ended or moved. Are you the organiser? Correct this listing.

Key numbers

Editions on record
1first in 2015

About GMP for combination products, a close look at 21 CFR Part 4

Overview:
The topic is the interpretation of the regulation 21 CFR Part 4, and the 2015 guidance which are rules for design and manufacturing controls for combination products. The regulation has been causing confusion since it was finalized in 2013, and this webinar will look at the regulation in terms of its history and the current practice of the Office of Compliance at CDRH.

We will outline what is meant by the regulations, in terms of new kinds of tests and data expected during manufacture for devices, and, new Quality Systems that will have to be incorporated for drugs.. This will be a concrete examination of the consequences these regulations have on affected products, and suggestion of ways to comply without adding a lot of extra staff and increasing COGS.

Why should you Attend: The rules at 21 CFR 4 are effective, which means that inspectors are using these rules to determine whether your combination product is adulterated and/or (in the case of expiration dates) mislabeled. From a 2014 warning letter: "In addition, please be advised that as a combination product manufacturer, you are subject to the requirements in 21 CFR Part 4, Current Good Manufacturing Practice Requirements for Combination Products, effective July 22, 2013. For example, you are required to have DHF's for your combination products under 21 CFR 820.30(j). See 21 CFR 4.4(b)(1)(ii). " Many combination products can successfully separate device and drug requirements because their manufacturing processes are completely separate for either component. However, other types of combination products require a merging of drug and device, CGMP with QSR, and there has been no new guidance to make the regulation any clearer.

From our listing of this edition. Details may have changed since.

Editions

YearDatesWhereExhibitorsVisitors
20153 Mar 2015Webinar Venue
Online
——

Past editions from the bvents archive (2008–2019) and organiser figures where they were published.

Questions

When is GMP for combination products, a close look at 21 CFR Part 4?

The next dates haven't been confirmed. The last edition we have on record was 3 Mar 2015.

Where is it held?

The last edition we have was at Webinar Venue, Palm Beach, Florida.

Who organises it?

Compliance4All.

Industries